LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 259 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $19,942,000 | -30.8% | 96,259 | -44.8% | 1.18% | -28.9% |
| Q1 2018 | $28,824,000 | +19.9% | 174,520 | -0.6% | 1.66% | +20.5% |
| Q4 2017 | $24,034,000 | -3.2% | 175,520 | -3.8% | 1.38% | -2.7% |
| Q3 2017 | $24,839,000 | +12.2% | 182,440 | 0.0% | 1.42% | +13.5% |
| Q2 2017 | $22,148,000 | +21.6% | 182,440 | +6.0% | 1.25% | +22.7% |
| Q1 2017 | $18,215,000 | +25.3% | 172,101 | +20.3% | 1.02% | +23.2% |
| Q4 2016 | $14,535,000 | +13.0% | 143,049 | +13.5% | 0.83% | +12.5% |
| Q3 2016 | $12,865,000 | +115.7% | 126,049 | +152.1% | 0.74% | +112.4% |
| Q2 2016 | $5,964,000 | +60.1% | 50,000 | +43.7% | 0.35% | +73.9% |
| Q1 2016 | $3,726,000 | +29.4% | 34,790 | -24.7% | 0.20% | +9.9% |
| Q2 2014 | $2,879,000 | – | 46,227 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |